Search research articles
Contact Us
Filters
Showing results (51-60 of 67) with videos related to
Page
of 7
Sort By:
European Urology Focus
|
July 30, 2017
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Bogdan-Alexandru Luca, Daniel S Brewer, Dylan R Edwards, et al.
The Prostate
|
August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates
Jonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
Endocrine-Related Cancer
|
September 1, 2016
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel
Benjamin C Thomas, Jonathan D Kay, Suraj Menon, et al.
European Urology
|
May 7, 2020
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort
Joseph M Norris, Lina M Carmona Echeverria, Simon R J Bott, et al.
Molecular Cancer
|
September 21, 2022
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Claudia Buhigas, Anne Y Warren, Wing-Kit Leung, et al.
Scientific Reports
|
October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists
Lina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
Radiology
|
December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial
Vasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
Cancer Research
|
November 29, 2013
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging
Michael D Allen, Phuong Luong, Chantelle Hudson, et al.
European Urology
|
October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS
Vasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
Nature
|
April 2, 2015
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 67) with videos related to
Sort By:
Page
of 7
European Urology Focus
|
July 30, 2017
DESNT: A Poor Prognosis Category of Human Prostate Cancer
Bogdan-Alexandru Luca, Daniel S Brewer, Dylan R Edwards, et al.
The Prostate
|
August 4, 2018
Immunohistochemical biomarker validation in highly selective needle biopsy microarrays derived from mpMRI-characterized prostates
Jonathan Olivier, Vasilis Stavrinides, Jonathan Kay, et al.
Endocrine-Related Cancer
|
September 1, 2016
Whole blood mRNA in prostate cancer reveals a four-gene androgen regulated panel
Benjamin C Thomas, Jonathan D Kay, Suraj Menon, et al.
European Urology
|
May 7, 2020
What Type of Prostate Cancer Is Systematically Overlooked by Multiparametric Magnetic Resonance Imaging? An Analysis from the PROMIS Cohort
Joseph M Norris, Lina M Carmona Echeverria, Simon R J Bott, et al.
Molecular Cancer
|
September 21, 2022
The architecture of clonal expansions in morphologically normal tissue from cancerous and non-cancerous prostates
Claudia Buhigas, Anne Y Warren, Wing-Kit Leung, et al.
Scientific Reports
|
October 15, 2020
A critical evaluation of visual proportion of Gleason 4 and maximum cancer core length quantified by histopathologists
Lina Maria Carmona Echeverria, Aiman Haider, Alex Freeman, et al.
Radiology
|
December 13, 2022
Regional Histopathology and Prostate MRI Positivity: A Secondary Analysis of the PROMIS Trial
Vasilis Stavrinides, Joseph M Norris, Solon Karapanagiotis, et al.
Cancer Research
|
November 29, 2013
Prognostic and therapeutic impact of argininosuccinate synthetase 1 control in bladder cancer as monitored longitudinally by PET imaging
Michael D Allen, Phuong Luong, Chantelle Hudson, et al.
European Urology
|
October 14, 2020
False Positive Multiparametric Magnetic Resonance Imaging Phenotypes in the Biopsy-naïve Prostate: Are They Distinct from Significant Cancer-associated Lesions? Lessons from PROMIS
Vasilis Stavrinides, Tom Syer, Yipeng Hu, et al.
Nature
|
April 2, 2015
The evolutionary history of lethal metastatic prostate cancer
Gunes Gundem, Peter Van Loo, Barbara Kremeyer, et al.
Page
of 7